116 related articles for article (PubMed ID: 38588758)
21. Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy.
Zhu X; Kong Y; Liu Q; Lu Y; Xing H; Lu X; Yang Y; Xu J; Li N; Zhao D; Chen X; Lu Y
Pulm Pharmacol Ther; 2019 Apr; 55():50-61. PubMed ID: 30738974
[TBL] [Abstract][Full Text] [Related]
22. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
23. Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy.
Chen J; Ning E; Wang Z; Jing Z; Wei G; Wang X; Ma P
Drug Deliv; 2021 Dec; 28(1):1389-1396. PubMed ID: 34180752
[TBL] [Abstract][Full Text] [Related]
24. Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel.
Raju A; Muthu MS; Feng SS
Expert Opin Drug Deliv; 2013 Jun; 10(6):747-60. PubMed ID: 23458409
[TBL] [Abstract][Full Text] [Related]
25. Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.
Wang S; Gou J; Wang Y; Tan X; Zhao L; Jin X; Tang X
Int J Nanomedicine; 2021; 16():2357-2372. PubMed ID: 33790554
[TBL] [Abstract][Full Text] [Related]
26. Chitosan-Coated Flexible Liposomes Magnify the Anticancer Activity and Bioavailability of Docetaxel: Impact on Composition.
Alshraim MO; Sangi S; Harisa GI; Alomrani AH; Yusuf O; Badran MM
Molecules; 2019 Jan; 24(2):. PubMed ID: 30641899
[TBL] [Abstract][Full Text] [Related]
27. Improved antitumor efficacy and reduced toxicity of docetaxel using anacardic acid functionalized stealth liposomes.
Kushwah V; Jain DK; Agrawal AK; Jain S
Colloids Surf B Biointerfaces; 2018 Dec; 172():213-223. PubMed ID: 30172202
[TBL] [Abstract][Full Text] [Related]
28. High throughput microfluidics-based synthesis of PEGylated liposomes for precise size control and efficient drug encapsulation.
Akar S; Fardindoost S; Hoorfar M
Colloids Surf B Biointerfaces; 2024 Jun; 238():113926. PubMed ID: 38677154
[TBL] [Abstract][Full Text] [Related]
29. Design and development of PEGylated liposomal formulation of HER2 blocker Lapatinib for enhanced anticancer activity and diminished cardiotoxicity.
Shrivastava R; Trivedi S; Singh PK; Asif M; Chourasia MK; Khanna A; Bhadauria S
Biochem Biophys Res Commun; 2018 Sep; 503(2):677-683. PubMed ID: 29908185
[TBL] [Abstract][Full Text] [Related]
30. Microfluidic Manufacturing of Liposomes: Development and Optimization by Design of Experiment and Machine Learning.
Rebollo R; Oyoun F; Corvis Y; El-Hammadi MM; Saubamea B; Andrieux K; Mignet N; Alhareth K
ACS Appl Mater Interfaces; 2022 Sep; 14(35):39736-39745. PubMed ID: 36001743
[TBL] [Abstract][Full Text] [Related]
31. Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells.
Gholizadeh S; Dolman EM; Wieriks R; Sparidans RW; Hennink WE; Kok RJ
Pharm Res; 2018 Mar; 35(4):85. PubMed ID: 29516187
[TBL] [Abstract][Full Text] [Related]
32. Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.
Manjappa AS; Goel PN; Gude RP; Ramachandra Murthy RS
J Drug Target; 2014 Sep; 22(8):698-711. PubMed ID: 24766186
[TBL] [Abstract][Full Text] [Related]
33. Microfluidic-assisted bacteriophage encapsulation into liposomes.
Leung SSY; Morales S; Britton W; Kutter E; Chan HK
Int J Pharm; 2018 Jul; 545(1-2):176-182. PubMed ID: 29729404
[TBL] [Abstract][Full Text] [Related]
34. Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity.
Gkionis L; Campbell RA; Aojula H; Harris LK; Tirella A
Int J Pharm; 2020 Nov; 590():119926. PubMed ID: 33010397
[TBL] [Abstract][Full Text] [Related]
35. A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: Formulation, cellular uptake and biodistribution investigations.
Lou G; Anderluzzi G; Woods S; Roberts CW; Perrie Y
Eur J Pharm Biopharm; 2019 Oct; 143():51-60. PubMed ID: 31445156
[TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.
Zhai G; Wu J; Xiang G; Mao W; Yu B; Li H; Piao L; Lee LJ; Lee RJ
J Nanosci Nanotechnol; 2009 Mar; 9(3):2155-61. PubMed ID: 19435095
[TBL] [Abstract][Full Text] [Related]
37. Iron complexation to histone deacetylase inhibitors SAHA and LAQ824 in PEGylated liposomes can considerably improve pharmacokinetics in rats.
Wang Y; Tu S; Steffen D; Xiong M
J Pharm Pharm Sci; 2014; 17(4):583-602. PubMed ID: 25579435
[TBL] [Abstract][Full Text] [Related]
38. Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.
Narayanaswamy R; Torchilin VP
Pharm Res; 2021 Mar; 38(3):429-450. PubMed ID: 33655395
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells.
Yang T; Choi MK; Cui FD; Lee SJ; Chung SJ; Shim CK; Kim DD
Pharm Res; 2007 Dec; 24(12):2402-11. PubMed ID: 17828616
[TBL] [Abstract][Full Text] [Related]
40. Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy.
Jadon RS; Sharma G; Garg NK; Tandel N; Gajbhiye KR; Salve R; Gajbhiye V; Sharma U; Katare OP; Sharma M; Tyagi RK
Colloids Surf B Biointerfaces; 2021 Jul; 203():111760. PubMed ID: 33872827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
